geriatrРоссийский журнал гериатрической медициныRussian Journal of Geriatric Medicine2686-86362686-8709Сайт издателя10.37586/2686-8636-4-2022-228-235geriatr-305Research ArticleОБЗОРЫREVIEWSСаркопеническое ожирение — актуальная проблема современной гериатрииSarcopenic obesity — a current problem of modern geriatricshttps://orcid.org/0000-0003-4114-5233КурмаевД. П.KurmaevD. P.

Курмаев Дмитрий Петрович - ассистент кафедры эндокринологии и гериатрии.

Самара, Телефон: +7(927)600-40-10

Kurmaev Dmitry P. - assistant professor of Endocrinology and Geriatrics Department.

Samara +7(927)600-40-10

geriatry@mail.ruhttps://orcid.org/0000-0003-0027-1786БулгаковаС. В.BulgakovaS. V.

Булгакова Светлана Викторовна - доктор медицинских наук, доцент, заведующая кафедрой эндокринологии и гериатрии.

Самара, телефон: +7(927)712-83-57

Bulgakova Svetlana V. - MD, PhD, professor, Head of the Department of Endocrinology and Geriatrics.

Samara +7(927)712-83-57

osteoporosis63@gmail.comhttps://orcid.org/0000-0003-0097-7252ТреневаЕ. В.TrenevaE. V.

Тренева Екатерина Вячеславовна - кандидат медицинских наук, доцент кафедры эндокринологии и гериатрии.

Самара, Телефон: +7(987)915-55-79

Treneva Ekaterina V. - MD, PhD, associate professor, Department of Endocrinology and Geriatrics.

Moscow +7(987)915-55-79

eka1006@yandex.ruСамарский государственный медицинский университетРоссияSamara State Medical UniversityRussian Federation20220102202304228235Copyright © Курмаев Д.П., Булгакова С.В., Тренева Е.В., 20232023Курмаев Д.П., Булгакова С.В., Тренева Е.В.Kurmaev D.P., Bulgakova S.V., Treneva E.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.geriatr-news.com/jour/article/view/305

Саркопеническое ожирение (СО) является сложным метаболическим состоянием организма, обусловленным синергическим сочетанием, взаимным усилением и отягощением патологических механизмов саркопении и ожирения. СО ассоциируется со снижением качества жизни, зависимостью от посторонней помощи, повышением риска инвалидизации и преждевременной смерти. В настоящее время актуальность проблемы СО возрастает в связи с глобальным демографическим старением населения, высокой частотой развития ожирения, сахарного диабета 2 типа (СД2), гериатрических синдромов саркопении и старческой астении в развитых странах современного мира. Представляет интерес обзор современных литературных данных распространенности, этиологии, патогенеза, а также принципов диагностики, профилактики и лечения саркопенического ожирения.

Sarcopenic obesity (SO) is a complex metabolic state of the body, attributable to a synergistic combination, mutual reinforcement and aggravation of the pathological mechanisms of sarcopenia and obesity. SO is associated with a decrease in the quality of life, dependence on outside help, an increased risk of disability and premature death. Currently, the urgency of the SO problem is increasing due to the global demographic aging of the population, the high incidence of obesity, type 2 diabetes mellitus (DM2), geriatric syndromes of sarcopenia and frailty in the developed countries of the modern world. It is of interest to review current literature data on the prevalence, etiology, pathogenesis, as well as the principles of diagnosis, prevention and treatment of sarcopenic obesity.

саркопеническое ожирениестарческая астениясаркопениягеронтологиягериатриябиоимпедансный анализполиморбидностьсахарный диабет 2 типаsarcopenic obesityfrailtysarcopeniagerontologygeriatricsbioimpedance analysispolymorbiditytype 2 diabetes mellitusReferencesDonini LM, Busetto L, Bischoff SC, et al. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321–335. https://doi.org/10.1159/000521241.Donini LM, Busetto L, Bischoff SC, et al. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321–335. https://doi.org/10.1159/000521241.Li CW, Yu K, Shyh-Chang N, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022;13(2):781–794. https://doi.org/10.1002/jcsm.12901.Li CW, Yu K, Shyh-Chang N, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022;13(2):781–794. https://doi.org/10.1002/jcsm.12901.Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico [published correction appears in Am J Epidemiol 1999 Jun 15;149(12):1161]. Am J Epidemiol. 1998;147(8):755–763. https://doi.org/10.1093/oxfordjournals.aje.a009520.Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico [published correction appears in Am J Epidemiol 1999 Jun 15;149(12):1161]. Am J Epidemiol. 1998;147(8):755–763. https://doi.org/10.1093/oxfordjournals.aje.a009520.Mayoral LP, Andrade GM, Mayoral EP, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020;151(1):11–21. https://doi.org/10.4103/ijmr.IJMR_1768_17.Mayoral LP, Andrade GM, Mayoral EP, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020;151(1):11–21. https://doi.org/10.4103/ijmr.IJMR_1768_17.Park SH, Park JH, Song PS, et al. Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens. 2013;7(6):420–425. https://doi.org/10.1016/j.jash.2013.06.002.Park SH, Park JH, Song PS, et al. Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens. 2013;7(6):420–425. https://doi.org/10.1016/j.jash.2013.06.002.Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437–448. https://doi.org/10.1111/j.1749-6632.2000.tb06498.x.Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437–448. https://doi.org/10.1111/j.1749-6632.2000.tb06498.x.Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693–700. https://doi.org/10.1097/MCO.0b013e328312c37d.Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693–700. https://doi.org/10.1097/MCO.0b013e328312c37d.Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388–395. https://doi.org/10.1016/j.numecd.2007.10.002.Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388–395. https://doi.org/10.1016/j.numecd.2007.10.002.El Ghoch M, Pellegrini M. Why should sarcopenic obesity be included in a routine assessment during weight-management programmes? Front Endocrinol (Lausanne). 2022;13:962895. https://doi.org/10.3389/fendo.2022.962895.El Ghoch M, Pellegrini M. Why should sarcopenic obesity be included in a routine assessment during weight-management programmes? Front Endocrinol (Lausanne). 2022;13:962895. https://doi.org/10.3389/fendo.2022.962895.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. https://doi.org/10.1093/ageing/afq034.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. https://doi.org/10.1093/ageing/afq034.Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. https://doi.org/10.1093/ageing/afz046.Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. https://doi.org/10.1093/ageing/afz046.Курмаев Д.П. Что первично: старческая астения или саркопения? (обзор литературы) / Д.П. Курмаев, С.В. Булгакова, Н.О. Захарова // Успехи геронтологии. — 2021. — Т. 34. — № 6. — С. 848–856. https://doi.org/10.34922/AE.2021.34.6.005.Kurmaev D.P., Bulgakova S.V., Zakharova N.O. What is primary: frailty or sarcopenia? (Literature review). Advances in Gerontology. 2021;34(6):848–856. (In Russ.). https://doi.org/10.34922/AE.2021.34.6.005.Клинические рекомендации «Старческая астения» / О.Н. Тка чева, Ю.В. Котовская, Н.К. Рунихина [и др.] // Российский журнал гериатрической медицины. — 2020. — № 1. — С. 11–46. https://doi.org/10.37586/2686-8636-1-2020-11-46.Tkacheva O.N., Kotovskaya Yu.V., Runikhina N.K. et al. Clinical guidelines on frailty. Russian Journal of Geriatric Medicine. 2020;(1):11–46. (In Russ.). https://doi.org/10.37586/2686-8636-1-2020-11-46.NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. https://doi.org/10.1016/S0140-6736(17)32129-3.NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. https://doi.org/10.1016/S0140-6736(17)32129-3.Batsis JA, Mackenzie TA, Emeny RT, Lopez-Jimenez F, Bartels SJ. Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999–2004 National Health and Nutrition Examination Survey. J Gerontol A Biol Sci Med Sci. 2017;72(10):1445–1451. https://doi.org/10.1093/gerona/glx002.Batsis JA, Mackenzie TA, Emeny RT, Lopez-Jimenez F, Bartels SJ. Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999–2004 National Health and Nutrition Examination Survey. J Gerontol A Biol Sci Med Sci. 2017;72(10):1445–1451. https://doi.org/10.1093/gerona/glx002.Lee DC, Shook RP, Drenowatz C, Blair SN. Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism. Future Sci OA. 2016;2(3):FSO127. https://doi.org/10.4155/fsoa-2016-0028.Lee DC, Shook RP, Drenowatz C, Blair SN. Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism. Future Sci OA. 2016;2(3):FSO127. https://doi.org/10.4155/fsoa-2016-0028.Johnson Stoklossa CA, Sharma AM, Forhan M, Siervo M, Padwal RS, Prado CM. Prevalence of Sarcopenic Obesity in Adults with Class II/III Obesity Using Different Diagnostic Criteria. J Nutr Metab. 2017;2017:7307618. https://doi.org/10.1155/2017/7307618.Johnson Stoklossa CA, Sharma AM, Forhan M, Siervo M, Padwal RS, Prado CM. Prevalence of Sarcopenic Obesity in Adults with Class II/III Obesity Using Different Diagnostic Criteria. J Nutr Metab. 2017;2017:7307618. https://doi.org/10.1155/2017/7307618.Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging. 2009;13(5):460– 466. https://doi.org/10.1007/s12603-009-0084-z.Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging. 2009;13(5):460– 466. https://doi.org/10.1007/s12603-009-0084-z.Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research. Medicina (Kaunas). 2019;55(9):546. https://doi.org/10.3390/medicina55090546.Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research. Medicina (Kaunas). 2019;55(9):546. https://doi.org/10.3390/medicina55090546.Hong SH, Choi KM. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci. 2020;21(2):494. https://doi.org/10.3390/ijms21020494.Hong SH, Choi KM. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci. 2020;21(2):494. https://doi.org/10.3390/ijms21020494.Khadra D, Itani L, Chebaro Y, et al. Association Between Sarcopenic Obesity and Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis. Curr Cardiol Rev. 2020;16(2):153–162. https://doi.org/10.2174/1573403X16666200214104122.Khadra D, Itani L, Chebaro Y, et al. Association Between Sarcopenic Obesity and Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis. Curr Cardiol Rev. 2020;16(2):153–162. https://doi.org/10.2174/1573403X16666200214104122.Wang M, Tan Y, Shi Y, Wang X, Liao Z, Wei P. Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments. Front Endocrinol (Lausanne). 2020;11:568. https://doi.org/10.3389/fendo.2020.00568.Wang M, Tan Y, Shi Y, Wang X, Liao Z, Wei P. Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments. Front Endocrinol (Lausanne). 2020;11:568. https://doi.org/10.3389/fendo.2020.00568.Иванникова, Е. В. Метаболизм мышечной ткани у лиц пожилого возраста / Е. В. Иванникова, Е. Н. Дудинская, Ю. С. Онучина // Российский журнал гериатрической медицины. — 2022. — № 2(10). — С. 96–102. https://doi.org/10.37586/2686-8636-2-2022-96-102.Ivannikova E.V., Dudinskaya E.N., Onuchina Yu.S. Muscle metabolism in older adults. Russian Journal of Geriatric Medicine. 2022;(2):96–102. (In Russ.). https://doi.org/10.37586/2686-8636-2-2022-96-102.Национальные клинические рекомендации по лечению морбидного ожирения у взрослых. 3-ий пересмотр (лечение морбидного ожирения у взрослых) / И.И. Дедов, Г.А. Мельниченко, М.В. Шестакова [и др.] // Ожирение и метаболизм. — 2018. — Т. 15. — № 1. — С. 53–70. https://doi.org/10.14341/omet2018153-70.Dedov I.I., Mel'nichenko G.A., Shestakova M.V. et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults). Obesity and metabolism. 2018;15(1):53–70. (In Russ.)]. https://doi.org/10.14341/omet2018153-70.Quiñones-Ossa GA, Lobo C, Garcia-Ballestas E, Florez WA, Moscote-Salazar LR, Agrawal A. Obesity and Stroke: Does the Paradox Apply for Stroke?. Neurointervention. 2021;16(1):9–19. DOI: 10.5469/neuroint.2020.00108.Quiñones-Ossa GA, Lobo C, Garcia-Ballestas E, Florez WA, Moscote-Salazar LR, Agrawal A. Obesity and Stroke: Does the Paradox Apply for Stroke?. Neurointervention. 2021;16(1):9–19. DOI: 10.5469/neuroint.2020.00108.Guo Y, Yue XJ, Li HH, et al. Overweight and Obesity in Young Adulthood and the Risk of Stroke: a Meta-analysis. J Stroke Cerebrovasc Dis. 2016;25(12):2995–3004. DOI: 10.1016/j.jstrokecerebrovasdis.2016.08.018.Guo Y, Yue XJ, Li HH, et al. Overweight and Obesity in Young Adulthood and the Risk of Stroke: a Meta-analysis. J Stroke Cerebrovasc Dis. 2016;25(12):2995–3004. DOI: 10.1016/j.jstrokecerebrovasdis.2016.08.018.Пигарова Е.А. Неклассические эффекты витамина D / Е.А. Пигарова, А.А. Петрушкина // Остеопороз и остеопатии. — 2017. — Т. 20. — № 3. — С. 90-101. https://doi.org/10.14341/osteo2017390-101.Pigarova EA, Petrushkina AA. Non-classical effects of vitamin D. Osteoporosis and bone diseases. 2017;20(3):90–101. (In Russ.). https://doi.org/10.14341/osteo2017390-101.Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13(2):261–270. https://doi.org/10.1007/s11892-012-0358-4.Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13(2):261–270. https://doi.org/10.1007/s11892-012-0358-4.Girgis CM, Clifton-Bligh RJ, Turner N, Lau SL, Gunton JE. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf). 2014;80(2):169–181. https://doi.org/10.1111/cen.12368.Girgis CM, Clifton-Bligh RJ, Turner N, Lau SL, Gunton JE. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf). 2014;80(2):169–181. https://doi.org/10.1111/cen.12368.Murad MH, Elamin KB, Abu Elnour NO, et al. Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis [published correction appears in J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1495]. J Clin Endocrinol Metab. 2011;96(10):2997–3006. https://doi.org/10.1210/jc.2011-1193.Murad MH, Elamin KB, Abu Elnour NO, et al. Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis [published correction appears in J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1495]. J Clin Endocrinol Metab. 2011;96(10):2997–3006. https://doi.org/10.1210/jc.2011-1193.Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения / Р. Г. Оганов, В. И. Симаненков, И. Г. Бакулин [и др.] // Кардиоваскулярная терапия и профилактика. — 2019. — Т. 18. — № 1. — С. 5–66. https://doi.org/10.15829/1728-8800-2019-1-5-66.Oganov R.G., Simanenkov V.I., Bakulin I.G. et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5–66. (In Russ.). https://doi.org/10.15829/1728-8800-2019-1-5-66.Kirwan R, McCullough D, Butler T, Perez de Heredia F, Davies IG, Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience. 2020;42(6):1547–1578. https://doi.org/10.1007/s11357-020-00272-3.Kirwan R, McCullough D, Butler T, Perez de Heredia F, Davies IG, Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience. 2020;42(6):1547–1578. https://doi.org/10.1007/s11357-020-00272-3.Maltese G, Corsonello A, Di Rosa M, et al. Frailty and COVID-19: A Systematic Scoping Review. J Clin Med. 2020;9(7):2106. https://doi.org/10.3390/jcm9072106.Maltese G, Corsonello A, Di Rosa M, et al. Frailty and COVID-19: A Systematic Scoping Review. J Clin Med. 2020;9(7):2106. https://doi.org/10.3390/jcm9072106.Silver JK. Prehabilitation May Help Mitigate an Increase in COVID-19 Peripandemic Surgical Morbidity and Mortality. Am J Phys Med Rehabil. 2020;99(6):459–463. https://doi.org/10.1097/PHM.0000000000001452.Silver JK. Prehabilitation May Help Mitigate an Increase in COVID-19 Peripandemic Surgical Morbidity and Mortality. Am J Phys Med Rehabil. 2020;99(6):459–463. https://doi.org/10.1097/PHM.0000000000001452.Piotrowicz K, Gąsowski J, Michel JP, Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33(10):2887–2898. https://doi.org/10.1007/s40520-021-01942-8.Piotrowicz K, Gąsowski J, Michel JP, Veronese N. PostCOVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33(10):2887–2898. https://doi.org/10.1007/s40520-021-01942-8.Pérez-Campos Mayoral L, Matias-Cervantes CA, Pérez-Campos E, et al. Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19. Int J Mol Sci. 2022;23(15):8277. https://doi.org/10.3390/ijms23158277.Pérez-Campos Mayoral L, Matias-Cervantes CA, PérezCampos E, et al. Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19. Int J Mol Sci. 2022;23(15):8277. https://doi.org/10.3390/ijms23158277.Fonseca-Pérez D, Arteaga-Pazmiño C, Maza-Moscoso CP, Flores-Madrid S, Álvarez-Córdova L. Food insecurity as a risk factor of sarcopenic obesity in older adults. Front Nutr. 2022;9:1040089. https://doi.org/10.3389/fnut.2022.1040089.Fonseca-Pérez D, Arteaga-Pazmiño C, Maza-Moscoso CP, Flores-Madrid S, Álvarez-Córdova L. Food insecurity as a risk factor of sarcopenic obesity in older adults. Front Nutr. 2022;9:1040089. https://doi.org/10.3389/fnut.2022.1040089.Мустафина, С. В. Сахарный диабет у пожилых пациентов в условиях новой коронавирусной инфекции (COVID-19) / С. В. Мустафина, А. П. Каширина // Российский журнал гериатрической медицины. — 2021. — № 4. — С. 414–419. https://doi.org/10.37586/2686-8636-4-2021-414-419.Mustafina S.V., Kashirina A.P. Diabetes mellitus in older patients under conditions of novel coronavirus infection (COVID-19). Russian Journal of Geriatric Medicine. 2021;(4):414–419. (In Russ.). https://doi.org/10.37586/2686-8636-4-2021-414-419.Старческая астения, саркопения и COVID-19 у гериатрических пациентов (обзор литературы) / Д.П. Курмаев, С.В. Булгакова, Е.В. Тренева, И.С. Четверикова // Успехи геронтологии. — 2022. — Т. 35. — № 5. — С. 726–736. https://doi.org/10.34922/AE.2022.35.5.009.Kurmaev D.P., Bulgakova S.V., Treneva E.V., Chetverikova I.S. Frailty, sarcopenia and COVID-19 in geriatric patients (Literature review). Advances in Gerontology. 2022;35(5):726–736. (In Russ.). https://doi.org/10.34922/AE.2022.35.5.009.Achamrah N, Colange G, Delay J, et al. Comparison of body composition assessment by DXA and BIA according to the body mass index: A retrospective study on 3655 measures. PLoS One. 2018;13(7):e0200465. https://doi.org/10.1371/journal.pone.0200465.Achamrah N, Colange G, Delay J, et al. Comparison of body composition assessment by DXA and BIA according to the body mass index: A retrospective study on 3655 measures. PLoS One. 2018;13(7):e0200465. https://doi.org/10.1371/journal.pone.0200465.Курмаев Д.П. Биоимпедансный анализ состава тела и фазовый угол в диагностике саркопении и старческой астении (обзор литературы) / Д.П. Курмаев, С.В. Булгакова, Е.В. Тренева // Успехи геронтологии. — 2022. — Т. 35. — № 2. — С. 294–301. https://doi.org/10.34922/AE.2022.35.2.014.Kurmaev D.P., Bulgakova S.V., Treneva E.V. Bioimpedance analysis of body composition and phase angle for the diagnosis of sarcopenia and frailty (Literature review). Advances in Gerontology. 2022;35(2):294–301. (In Russ.). https://doi.org/10.34922/AE.2022.35.2.014.Ceravolo MG, de Sire A, Andrenelli E, Negrini F, Negrini S. Systematic rapid «living» review on rehabilitation needs due to COVID-19: update to March 31st, 2020. Eur J Phys Rehabil Med. 2020;56(3):347–353. https://doi.org/10.23736/S1973-9087.20.06329-7.Ceravolo MG, de Sire A, Andrenelli E, Negrini F, Negrini S. Systematic rapid «living» review on rehabilitation needs due to COVID-19: update to March 31st, 2020. Eur J Phys Rehabil Med. 2020;56(3):347–353. https://doi.org/10.23736/S1973-9087.20.06329-7.Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513–537. https://doi.org/10.1038/s41574-018-0062-9.Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513–537. https://doi.org/10.1038/s41574-018-0062-9.Koliaki C, Liatis S, Dalamaga M, Kokkinos A. Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives. Curr Obes Rep. 2019;8(4):458–471. https://doi.org/10.1007/s13679-019-00359-9.Koliaki C, Liatis S, Dalamaga M, Kokkinos A. Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives. Curr Obes Rep. 2019;8(4):458–471. https://doi.org/10.1007/s13679-019-00359-9.Sukkar SG, Muscaritoli M. A Clinical Perspective of Low Carbohydrate Ketogenic Diets: A Narrative Review. Front Nutr. 2021;8:642628. Published 2021 Jul 12. DOI: 10.3389/fnut.2021.642628.Sukkar SG, Muscaritoli M. A Clinical Perspective of Low Carbohydrate Ketogenic Diets: A Narrative Review. Front Nutr. 2021;8:642628. Published 2021 Jul 12. DOI: 10.3389/fnut.2021.642628.Freire R. Scientific evidence of diets for weight loss: Different macronutrient composition, intermittent fasting, and popular diets. Nutrition. 2020;69:110549. DOI: 10.1016/j.nut.2019.07.001.Freire R. Scientific evidence of diets for weight loss: Different macronutrient composition, intermittent fasting, and popular diets. Nutrition. 2020;69:110549. DOI: 10.1016/j.nut.2019.07.001.Camajani E, Feraco A, Proietti S, et al. Corrigendum: Very low calorie ketogenic diet combined with physical interval training for preserving muscle mass during weight loss in sarcopenic obesity: A pilot study. Front Nutr. 2022;9:1076667. https://doi.org/10.3389/fnut.2022.1076667.Camajani E, Feraco A, Proietti S, et al. Corrigendum: Very low calorie ketogenic diet combined with physical interval training for preserving muscle mass during weight loss in sarcopenic obesity: A pilot study. Front Nutr. 2022;9:1076667. https://doi.org/10.3389/fnut.2022.1076667.Barrea L, de Alteriis G, Muscogiuri G, et al. Impact of a Very Low-Calorie Ketogenic Diet (VLCKD) on Changes in Handgrip Strength in Women with Obesity. Nutrients. 2022;14(19):4213. DOI: 10.3390/nu14194213.Barrea L, de Alteriis G, Muscogiuri G, et al. Impact of a Very Low-Calorie Ketogenic Diet (VLCKD) on Changes in Handgrip Strength in Women with Obesity. Nutrients. 2022;14(19):4213. DOI: 10.3390/nu14194213.Chen SH, Liang YJ. The Role of Lifestyle Intervention, in Addition to Drugs, for Diabetic Kidney Disease with Sarcopenic Obesity. Life (Basel). 2022;12(3):380. https://doi.org/10.3390/life12030380.Chen SH, Liang YJ. The Role of Lifestyle Intervention, in Addition to Drugs, for Diabetic Kidney Disease with Sarcopenic Obesity. Life (Basel). 2022;12(3):380. https://doi.org/10.3390/life12030380.

The authors declare that there are no conflicts of interest present.